Ambey Laboratories IPO GMP, subscription status: Should you apply | Expert Review

Ambey Laboratories IPO GMP, subscription status: Should you apply | Expert Review

New Delhi: Ambey Laboratories IPO will close on Monday, July 08, 2024. Ambey Laboratories IPO GMP has remained firm and hasn’t gone up too much ever since the stake sale process kicked-off on 4th. The IPO subscription status has gradually become multifold with the total IPO size of Rs 44 crore.

Stock market analyst Sharad Mishra has advised that retail investors can apply for the SME IPO but with a long term perspective. While appearing on Money9, the expert said, “Investors shouldn’t apply in this SME IPO purely for listing gains.”

Also read: Expert’s view on Mazagon Dock, Zen Tech, KPI Green, Happy Forgings!

Ambey Laboratories IPO GMP today

Ambey Laboratories IPO GMP stands at Rs 44 in the grey market, according to Investor Gain. The company’s stock’s grey market premium signifies that the shares are expected to list with a gain of nearly 65 per cent. Albeit, GMP cannot be considered as an official number.

Ambey Laboratories IPO Subscription Status

Ambey Laboratories IPO Subscription Status reached 42 times by the end of day two on July 4. Ambey Laboratories IPO retail subscription status reached nearly 65X. The IPO was oversubscribed 50 times the alloted size in the Non Institutional Investors (NIIs) category. Retail investors can bid for a minimum of 2,000 shares in a single lot and in multiples thereof. At lower price of the IPO price band, retail investors will have to invest a minimum of Rs 1.30 lakh.

Ambey Laboratories IPO Allotment Date

Ambey Laboratories IPO allotment is expected on July 9, 2024. The shares are expected to be credited to the demat accounts of eligible investors on July 10, and are likely to be listed on July on the NSE SME.

Also read: Stocks to buy: SJVN, Jindal, Steel & Power and more!

(Disclaimer: This article is only meant to provide information. News9live.com does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)

 According to stock market analyst Sharad Mishra, retail investors can apply in the Ambey Laboratories SME IPO but for the long term.  Markets Business News – Personal Finance News, Share Market News, BSE/NSE News, Stock Exchange News Today